About
Services and plasma-derived medicinal products
Areas of Focus
Categories
Biologics & BiopharmaceuticalContract Manufacturing
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
15
As Collaborator
10
Total Enrollment
2,073
By Phase
PHASE4: 7PHASE1/PHASE2: 2PHASE3: 7PHASE2/PHASE3: 3PHASE2: 4PHASE1: 1
By Status
COMPLETED: 16TERMINATED: 5UNKNOWN: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06004986Collaborator
DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema
PHASE4Recruiting
216 participants
Started: Aug 14, 2023 · Completed: Dec 31, 2025
NCT05205863Lead Sponsor
Dose-Response in PD and Safety of Cofact Under VKA Anticoagulation
PHASE1/PHASE2Completed
69 participants
Started: Nov 12, 2021 · Completed: Sep 3, 2022
NCT04589949Collaborator
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)
PHASE3Terminated
420 participants
Started: Oct 12, 2020 · Completed: Mar 1, 2022
NCT04342182Collaborator
Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)
PHASE2/PHASE3Terminated
86 participants
Started: Apr 8, 2020 · Completed: Sep 30, 2020
NCT04024202Collaborator
Data Registry of Auto Immune Hemolytic Anemia
N/AUnknown
720 participants
Started: Jul 12, 2019 · Completed: Dec 1, 2024
Locations (1)
Headquarters
Brussels, Belgium
Map
Loading map...